| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
PMV Pharmaceuticals, Inc.
13G/A
PMVP · 69353Y103
|
4.9% |
5/15/2026
Event 3/31/2026
|
||||
| Euclidean Capital LLC | 4.9% | |||||
| Marilyn H. Simons | 4.9% | |||||
| Ashvin B. Chhabra | 4.9% | |||||
| Greenland NFP B Ltd. | 2.4% | |||||
| Greenland NFP LLC | 0.1% | |||||
| Greenland A LLC | 0.7% | |||||
| Symmetry Group Ltd. | 0.5% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.